Do calcium supplements cause heart disease?

Calcium supplements do not directly cause heart disease in most women. However, some randomized trials suggest a modest increase in myocardial infarction risk in postmenopausal women taking supplemental calcium. The absolute risk increase appears small but may be relevant in women with high cardiovascular risk.

Are calcium supplements linked to heart attacks?

Some meta-analyses have reported a small increase in heart attack risk associated with calcium supplements, particularly in postmenopausal women. The increase is modest in absolute terms, often measured as several additional events per 1,000 women over five years.

Is dietary calcium safer than calcium supplements for the heart?

Current evidence suggests dietary calcium from food sources may be safer than high-dose calcium supplements. Food-based calcium is absorbed more gradually and does not produce the same short-term serum calcium spikes seen with pill-based supplementation.

Should postmenopausal women stop taking calcium supplements?

Not necessarily. The decision should be individualized based on bone density, fracture risk, dietary calcium intake, and overall cardiovascular risk. Women should discuss supplementation with their cardiologist or primary care physician.

How much calcium should women over 50 take daily?

Women over 50 are generally advised to consume about 1,200 mg of calcium per day from diet and supplements combined. It is usually recommended to prioritize dietary sources and avoid exceeding the upper intake level unless medically indicated.

Biotin Interference with Lab Tests: How It Affects Troponin Testing

Dr. Arash Bereliani
Jun 4
6 min read

Biotin interference with lab tests is an important but often overlooked issue in medical diagnostics. Biotin, also known as vitamin B7, is a water-soluble vitamin found in many dietary supplements and beauty products that claim to support hair, skin, and nail health. However, when taken in high doses, biotin can distort laboratory test results, including critical cardiac biomarker tests such as troponin testing. The FDA has issued multiple safety communications warning clinicians and consumers about these risks. Understanding how biotin interacts with immunoassay-based testing methods is essential to prevent misdiagnosis, especially in cases involving heart attack evaluation.

What Is Biotin and Why Is It Taken?

Biotin, or vitamin B7, plays a vital role in metabolism by helping convert food into energy. It is naturally present in foods such as eggs, salmon, almonds, and sweet potatoes. While the recommended daily allowance (RDA) is only 0.03 mg, many biotin supplements on the market contain up to 20 mg—a dosage that is hundreds of times higher than typical dietary intake.

These high-dose supplements are frequently marketed for cosmetic benefits like faster hair growth or stronger nails. However, research from the National Institutes of Health and Harvard Health Publications has shown limited scientific support for these claims. For most people, a balanced diet provides sufficient biotin, making additional supplementation unnecessary.

Understanding Biotin Interference with Lab Tests

Biotin interference with lab tests occurs because many modern immunoassays use a biotin-streptavidin interaction to capture target molecules. When excessive biotin is present in a patient’s blood sample, it can disrupt this biochemical binding process. Depending on the test, biotin may cause either falsely high or falsely low results.

In cardiac care, this interference is particularly concerning. Cardiac troponin tests are among the most important blood tests used to detect myocardial injury, which helps doctors diagnose heart attacks. If a patient takes high doses of biotin, their troponin levels may appear falsely low, leading to a missed diagnosis of a heart attack. That delay in care can have serious or even fatal consequences.

How does biotin interfere with cardiac troponin testing?

Troponin testing relies on immunoassays that use special antibodies to detect troponin—a protein released into the bloodstream when the heart muscle is damaged. These assays often employ biotin-based binding technology to capture and measure troponin concentrations accurately. When a blood sample contains excess biotin, the binding process can fail, resulting in inaccurately low readings. Since troponin is a key cardiac biomarker, these inaccuracies can affect emergency medical decisions.

FDA Warnings and Safety Communications

The FDA first issued warnings in 2017 following reports of false troponin results, including a patient death linked to biotin interference. The agency emphasized that high doses of biotin can cause incorrect readings in several types of immunoassays, such as cardiac biomarker tests and hormone panels like thyroid-stimulating hormone (TSH) assays.

To increase transparency, the FDA now publishes a list of affected devices and assays. This list includes specific testing platforms like the Roche Elecsys Troponin T Gen 5 STAT and the Siemens ADVIA Centaur TnI-Ultra systems, both of which have been documented to show susceptibility to biotin-related errors. Some manufacturers have since modified their testing systems to minimize interference, yet others continue to work toward full resolution. This transparency initiative has improved clinician awareness but also highlighted that complete mitigation remains an ongoing process.

FDA's ongoing monitoring of biotin interference

Even years after its initial safety communication, the FDA continues to receive adverse event reports related to biotin interference in lab tests. Several diagnostic developers have improved their assays to resist interference, but some systems still pose risks to patient safety. The agency encourages healthcare providers to check whether their laboratory’s assay methods have been updated to address biotin problems.

Which Lab Tests Are Affected by High Biotin Intake?

While the most serious implications of biotin interference occur in troponin testing, other assays are also affected. These include thyroid hormone tests, reproductive hormone panels, and certain cancer biomarkers, among others. Because biotin is used as a binding agent in many immunoassays, its impact extends beyond cardiac diagnostics.

For emergency physicians and clinical laboratories, the ability to recognize patterns of inconsistent lab results is essential. If a patient’s test results do not align with their physical symptoms, biotin interference should be considered as a possible factor.

What biotin dose can cause false heart attack results?

Supplements marketed for hair and nail growth can contain between 5 mg and 20 mg of biotin. In clinical settings, patients being treated for multiple sclerosis may take doses up to 300 mg per day under medical supervision. These amounts can saturate the bloodstream for several days, leading to significant distortion of test results, particularly for troponin and hormone assays.

How Biotin Interference Affects Troponin Blood Tests

Troponin blood tests measure cardiac troponin I or T to help identify heart muscle injury. The accuracy of these tests is critical for diagnosing acute myocardial infarction, or heart attack. Biotin interference in troponin tests can cause misinterpretation of cardiac enzyme assay results, potentially resulting in delayed diagnosis, unnecessary hospital discharge, or missed treatment.

When a patient taking high-dose biotin presents with chest pain, their cardiac troponin levels may appear within the normal range even if heart damage has occurred. This creates a serious diagnostic hazard that healthcare providers must recognize.

Can biotin use interfere with heart attack blood tests?

Yes. Biotin use can cause false-negative results in heart attack blood tests. This means that the test might not detect elevated troponin levels when the patient is, in fact, experiencing cardiac injury. Because of this risk, the FDA urges physicians to ask patients about supplement usage during intake evaluation.

Steps Healthcare Providers Can Take to Reduce Risk

Healthcare providers can take several steps to prevent misinterpretation of lab results due to biotin laboratory test interference:

Ask about supplement use: During intake or emergency assessment, clinicians should routinely ask patients about vitamin and supplement use, especially if symptoms suggest heart or thyroid conditions.
Confirm abnormal results: If a test result does not match the patient’s clinical presentation, labs should verify whether biotin interference is possible and consider running the test with an assay resistant to biotin.
Educate patients: Inform patients that biotin supplements can distort critical blood test results, particularly during cardiac evaluations.
Follow FDA updates: Stay informed about assays still susceptible to interference by consulting the FDA’s updated list of affected test platforms.

How can healthcare providers prevent biotin interference in cardiac assays?

Prevention begins with awareness. Laboratories should maintain internal protocols that identify which of their assays use biotin-streptavidin chemistry. When feasible, laboratories can select newer assays engineered to tolerate high biotin levels. In urgent cardiac testing, labs may delay testing for at least 8 hours after supplement intake, depending on dosage, to reduce error.

What Should Consumers Know About Biotin and Lab Test Accuracy?

For consumers, especially those taking high-dose biotin supplements for hair growth or wellness, transparency with healthcare providers is critical. Patients should always disclose supplement use before blood work. If they are scheduled for critical lab tests such as cardiac biomarker analyses or hormone panels, they may need to pause high-dose supplement intake 48 to 72 hours prior, as advised by their doctor.

Should you stop taking biotin before a troponin blood test?

Yes, in most cases, temporarily discontinuing biotin supplements before troponin or thyroid testing is advisable. However, discontinuation should be guided by a healthcare professional based on dosage and medical condition. This precaution helps ensure that results are accurate and reflective of true health status.

The Ongoing Importance of Biotin Interference Awareness

Despite increased awareness since the FDA’s original warning, reports continue to surface about biotin affecting cardiac troponin testing. Biotin interference remains a recognized patient safety issue in both emergency and routine medical diagnostics. Clinicians, laboratories, and supplement users share responsibility for reducing its impact.

The FDA’s commitment to publishing affected assay lists and encouraging mitigation efforts represents significant progress. However, consistent education, responsible supplement use, and vigilant laboratory practices remain essential to protect patient outcomes.

Conclusion

Biotin interference with lab tests, especially those measuring cardiac troponin, highlights how even widely used vitamins can disrupt critical medical diagnostics. Understanding the interaction between biotin and immunoassay-based testing is vital for patients, clinicians, and laboratories. By asking the right questions, verifying abnormal results, and staying informed on FDA developments, healthcare providers can prevent misdiagnoses that could otherwise have life-threatening consequences. For consumers, the simplest takeaway is to discuss all supplement usage with healthcare teams to ensure the most accurate laboratory test results possible.